The global pharmaceutical drug delivery market is undergoing significant transformation as pharmaceutical companies increasingly focus on improving therapeutic efficacy, patient adherence, dosing precision, and convenience. The growing prevalence of chronic diseases, expanding use of biologics, and development of complex therapies are accelerating demand for innovative drug delivery systems and advanced drug delivery technologies.
According to MarketsandMarkets™, the Pharmaceutical Drug Delivery Market is projected to reach USD 2,922.82 billion by 2031, up from USD 2,152.45 billion in 2026, registering a CAGR of 6.3% during the forecast period.
The market covers drug delivery solutions across oral, injectable, topical, ocular, nasal, transmucosal, implantable, pulmonary, and transdermal routes of administration, with applications spanning cancer, diabetes, cardiovascular diseases, and other therapeutic areas.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1085
Pharmaceutical Drug Delivery Market Report
The MarketsandMarkets™ report, “Pharmaceutical Drug Delivery Market by Administration Route (Oral, Injectable, Topical, Ocular, Nasal, Transmucosal & Implantable, Pulmonary, Transdermal Patch), Application (Cancer, Diabetes, Cardiovascular), Facility of Use – Global Forecast to 2031,” provides an in-depth assessment of market trends, growth opportunities, competitive dynamics, technologies, and regional developments.
The report includes 1,700 market data tables, 300 figures, 1,500 pages, and an in-depth Table of Contents.
Read the full report and access the detailed Table of Contents:
What Are Drug Delivery Systems?
Drug delivery systems are technologies and formulations designed to administer pharmaceutical compounds to specific sites in the body while controlling factors such as dosage, absorption, distribution, release, and therapeutic exposure.
The National Library of Medicine defines drug delivery systems as systems used to deliver drugs to target sites of pharmacological action. Related concepts include drug targeting, drug carriers, dosage forms, and different drug administration routes.
Modern drug delivery technology is increasingly moving beyond conventional tablets and injections toward patient-centric and targeted solutions, including:
- Advanced injectable drug delivery systems
- Autoinjectors
- Prefilled syringes
- Wearable injectors
- Inhalation drug delivery
- Transdermal patches
- Implantable drug delivery systems
- Controlled-release formulations
- Nanoparticle-based delivery
- Lipid nanoparticle delivery
- Targeted drug delivery
- Long-acting drug delivery technologies
These innovations are particularly important for biologics, vaccines, mRNA therapies, cell and gene therapies, and high-viscosity formulations.
Key Growth Drivers in the Pharmaceutical Drug Delivery Market
Rising Prevalence of Chronic Diseases
The increasing global burden of cancer, diabetes, cardiovascular diseases, autoimmune disorders, and other chronic conditions is generating sustained demand for pharmaceutical treatments.
Many chronic therapies require regular and precise administration, creating opportunities for innovative drug delivery devices and formulations that can reduce dosing frequency while improving patient convenience.
Increasing Adoption of Biologics and Complex Therapies
Biologics and other complex therapeutic products often present challenges related to stability, absorption, bioavailability, and administration.
Consequently, pharmaceutical manufacturers are investing in advanced delivery platforms capable of supporting high-molecular-weight molecules, high-viscosity formulations, and sensitive biological products.
Shift Toward Self-Administration
Healthcare is increasingly shifting toward outpatient and home-based treatment models.
Autoinjectors, prefilled syringes, wearable injectors, and other drug delivery devices can enable patients to administer therapies outside traditional hospital environments.
This shift can improve convenience while potentially reducing healthcare-resource requirements.
Growing Demand for Targeted Drug Delivery
Targeted drug delivery aims to deliver therapeutic agents to specific tissues, cells, or biological sites. The objective is to improve therapeutic exposure while minimizing unwanted effects.
Targeted and controlled drug delivery approaches are particularly relevant to oncology and other complex therapeutic areas.
Advancements in Controlled-Release Formulations
Controlled-release technologies are becoming increasingly important because they can regulate the release of active pharmaceutical ingredients over a defined period.
Research literature also identifies controlled release, drug delivery systems, and drug formulation among important areas of drug-delivery research.
Injectable Drug Delivery Is Expected to Remain a Major Market Segment
Among the various routes of administration, injectable drug delivery is positioned as a major segment of the pharmaceutical drug delivery market.
The growing use of biologics, biosimilars, vaccines, monoclonal antibodies, and advanced therapies is supporting demand for injectable delivery technologies.
Injectable drug delivery offers several advantages, including:
- Precise dosing
- Rapid therapeutic action
- High bioavailability
- Administration of complex biologics
- Reduced dependence on gastrointestinal absorption
- Compatibility with long-acting formulations
Technologies such as prefilled syringes, autoinjectors, and wearable injectors are further changing how injectable therapies are administered.
The growing emphasis on self-administration is also creating opportunities for pharmaceutical companies and medical-device manufacturers developing patient-centric delivery platforms.
Oral Drug Delivery Continues to Be Highly Important
Oral drug delivery remains one of the most established routes of pharmaceutical administration because of its convenience, familiarity, and ease of use.
The pharmaceutical industry continues to invest in oral delivery technologies designed to improve drug stability, absorption, bioavailability, and release characteristics.
Innovations include:
- Oral controlled-release formulations
- Oral thin films
- Modified-release tablets
- Capsules
- Drug-in-food technologies
- Advanced oral formulations
- Gastrointestinal-targeted delivery
Market research also identifies oral drug delivery as a major product category within the pharmaceutical drug delivery industry.
Advanced Drug Delivery Systems Transforming Healthcare
The evolution from conventional formulations toward advanced drug delivery systems is one of the most important trends shaping the market.
Advanced delivery platforms can help address challenges associated with drug solubility, stability, absorption, dosing frequency, and targeted administration.
Key technologies include:
Nanoparticle Drug Delivery
Nanoparticle-based systems can be engineered to improve drug solubility, stability, bioavailability, and targeting.
Lipid Nanoparticle Drug Delivery
Lipid nanoparticles have gained strategic importance as delivery platforms for nucleic-acid-based therapies, including mRNA technologies.
Transdermal Drug Delivery
Transdermal drug delivery enables pharmaceutical compounds to pass through the skin and enter systemic circulation.
Research on transdermal drug delivery has highlighted technologies such as microneedles, iontophoresis, nanoparticles, hydrogels, and permeation-enhancing approaches.
Pulmonary Drug Delivery
Pulmonary delivery enables pharmaceutical compounds to reach the respiratory system through inhalation. It is relevant to respiratory diseases and can also provide opportunities for systemic drug administration.
Implantable Drug Delivery
Implantable systems can provide controlled and sustained drug release and may be particularly useful when prolonged therapeutic exposure is required.
Asia Pacific Pharmaceutical Drug Delivery Market Outlook
Asia Pacific is expected to record the highest growth rate in the pharmaceutical drug delivery market between 2026 and 2031.
The region is benefiting from:
- Increasing healthcare expenditure
- Large and growing patient populations
- Rising prevalence of chronic diseases
- Expanding pharmaceutical manufacturing
- Increasing adoption of biologics and biosimilars
- Growing healthcare infrastructure
- Government initiatives supporting pharmaceutical production
- Expansion of contract development and manufacturing organizations
- Increasing demand for self-administration technologies
China, India, and Japan are particularly important markets within the region.
The India pharmaceutical drug delivery market alone is projected by MarketsandMarkets™ to grow from USD 16.74 billion in 2026 to USD 17.63 billion by 2031, representing a CAGR of 2.0%.
Pharmaceutical Drug Delivery Market: Key Challenges
Despite strong growth opportunities, the industry faces several challenges.
High Development Costs
Developing advanced drug delivery systems can require substantial investment in formulation development, device engineering, clinical testing, manufacturing, and regulatory compliance.
Complex Drug-Device Combination Products
Combination products that integrate pharmaceuticals with delivery devices can introduce additional technical and regulatory requirements.
Manufacturers must demonstrate the safety, effectiveness, usability, and performance of both the drug and delivery platform.
Regulatory Complexity
Regulatory requirements continue to evolve across major markets, including the US, Europe, Japan, China, and India.
Companies must comply with increasingly rigorous requirements covering product quality, device performance, usability, manufacturing, and patient safety.
Manufacturing Complexity
Advanced delivery technologies can require specialized manufacturing processes, materials, equipment, and quality-control systems.
These factors can increase production costs and extend development timelines.
Competitive Landscape
The global pharmaceutical drug delivery market includes major pharmaceutical companies as well as specialized drug-delivery device manufacturers.
Prominent pharmaceutical players include Johnson & Johnson Services, Pfizer, F. Hoffmann-La Roche, Eli Lilly and Company, Novartis, GSK, AbbVie, Sanofi, Merck & Co., and Amgen.
Important companies in the drug delivery devices segment include BD, Cardinal Health, SHL Medical, Gerresheimer, and Stevanato Group.
These companies are pursuing strategies such as product launches, partnerships, acquisitions, collaborations, geographic expansion, and technology development to strengthen their positions in the evolving drug delivery ecosystem.
Future Trends in Drug Delivery Technology
The future of pharmaceutical drug delivery is expected to be shaped by the convergence of pharmaceuticals, medical devices, biotechnology, materials science, and digital technologies.
Key trends to watch include:
- Self-administered drug delivery
- Wearable drug delivery devices
- Long-acting injectable formulations
- Targeted drug delivery systems
- Nanoparticle drug delivery
- Lipid nanoparticle technologies
- Microneedle drug delivery
- Smart drug delivery systems
- Connected drug delivery devices
- AI-enabled drug formulation and delivery development
- Home-based drug administration
- Drug delivery for biologics and gene therapies
Research into artificial intelligence and drug delivery is also expanding, with AI and machine-learning approaches being investigated for formulation optimization, drug-excipient interaction prediction, and delivery-material screening.
Pharmaceutical Drug Delivery Market: Key Takeaways
The pharmaceutical drug delivery industry is moving toward more precise, convenient, targeted, and patient-centric drug administration.
The most important market opportunities are emerging from the increasing use of biologics, rising chronic disease prevalence, home healthcare, self-administration, controlled-release technologies, and advanced delivery platforms.
Injectable drug delivery is expected to remain a major growth area, while oral, transdermal, pulmonary, nasal, ocular, implantable, and targeted drug delivery technologies continue to evolve.
At the regional level, Asia Pacific is positioned as an important high-growth market, supported by expanding healthcare infrastructure, pharmaceutical manufacturing capabilities, and demand for advanced therapeutics.
Overall, continued innovation in drug delivery systems, drug delivery devices, advanced formulations, targeted delivery, and connected technologies is expected to create significant opportunities for pharmaceutical manufacturers, biotechnology companies, medical-device companies, and technology providers through 2031.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=1085